The Lancet Commission on lessons for the future from the COVID-19 pandemic

JD Sachs, SSA Karim, L Aknin, J Allen, K Brosbøl… - The Lancet, 2022 - thelancet.com
Executive summary As of May 31, 2022, there were 6· 9 million reported deaths and 17· 2
million estimated deaths from COVID-19, as reported by the Institute for Health Metrics and …

COVID-19 in children: where do we stand?

GB Nikolopoulou, HC Maltezou - Archives of medical research, 2022 - Elsevier
From the beginning of the coronavirus disease 2019 (COVID-19) pandemic it became
evident that children infected with the severe acute respiratory syndrome coronavirus 2 …

Post-acute sequelae of covid-19 six to 12 months after infection: population based study

RS Peter, A Nieters, HG Kräusslich, SO Brockmann… - Bmj, 2022 - bmj.com
Objectives To describe symptoms and symptom clusters of post-covid syndrome six to 12
months after acute infection, describe risk factors, and examine the association of symptom …

COVID–19 and chronic kidney disease: an updated overview of reviews

SS Jdiaa, R Mansour, A El Alayli, A Gautam… - Journal of …, 2022 - Springer
Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

Pre-existing health conditions and severe COVID-19 outcomes: an umbrella review approach and meta-analysis of global evidence

M Treskova-Schwarzbach, L Haas, S Reda, A Pilic… - BMC medicine, 2021 - Springer
Background This study applies an umbrella review approach to summarise the global
evidence on the risk of severe COVID-19 outcomes in patients with pre-existing health …

Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe

CI Vardavas, AG Mathioudakis… - European …, 2022 - Eur Respiratory Soc
Background As mortality from coronavirus disease 2019 (COVID-19) is strongly age-
dependent, we aimed to identify population subgroups at an elevated risk for adverse …

Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

B Yurttas, BC Poyraz, N Sut, A Ozdede, M Oztas… - Rheumatology …, 2021 - Springer
Objectives Vaccination against COVID-19 emerges as an effective strategy for combating
the pandemic. While many of our patients with rheumatic diseases (RD) wonder whether it is …

[HTML][HTML] Smoking and risk of negative outcomes among COVID-19 patients: A systematic review and meta-analysis

A Umnuaypornlert, S Kanchanasurakit… - Tobacco induced …, 2021 - ncbi.nlm.nih.gov
METHODS Electronic databases, including PubMed, EMBASE, Cochrane Library, Science
Direct, Google Scholar, were systematically searched from the initiation of the database until …

International travel‐related control measures to contain the COVID‐19 pandemic: a rapid review

Cochrane Public Health Group, J Burns… - Cochrane Database …, 1996 - cochranelibrary.com
Background In late 2019, the first cases of coronavirus disease 2019 (COVID‐19) were
reported in Wuhan, China, followed by a worldwide spread. Numerous countries have …

[HTML][HTML] Clinical outcomes and quality of life of COVID-19 survivors: a follow-up of 3 months post hospital discharge

BC Todt, C Szlejf, E Duim, AOM Linhares, D Kogiso… - Respiratory …, 2021 - Elsevier
Background Over 66 million people worldwide have been diagnosed with COVID-19.
Therefore, understanding their clinical evolution beyond hospital discharge is essential not …